Rohin Patel

Stock Analyst at JP Morgan

(n/a)

# 4,829

Out of 5,049 analysts

3

Total ratings

n/a

Success rate

-38.89%

Average return

Main Sectors:

Top Industries:

Medical Devices

Stocks Rated by Rohin Patel

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	NPCE NeuroPace	Maintains: Overweight	$16 → $18	$12.78	+40.85%	1	Nov 5, 2025
	HAE Haemonetics	Downgrades: Neutral	$85 → $62	$67.11	-7.61%	2	Aug 8, 2025

NeuroPace

Nov 5, 2025

Maintains: Overweight

Price Target: $16 → $18

Current: $12.78

Upside: +40.85%

Haemonetics

Aug 8, 2025

Downgrades: Neutral

Price Target: $85 → $62

Current: $67.11

Upside: -7.61%